LEWISVILLE, Texas–(BUSINESS
WIRE)–Orthofix International N.V., (the Company) announced today the full
U.S. launch of two differentiated internal fixation repair solutions for the
foot and ankle market with the Centronail Ankle Compression Nailing and
Contours Lapidus Plating Systems.
Centronail Ankle Compression Nailing (ACN) System
With the U.S.
launch of the Centronail Ankle Compression Nailing (ACN) System, Orthofix now
has a differentiated solution for hindfoot fusions. This procedure treats
patients who suffer from debilitating pain and incapacity as a result of
arthritis, trauma, and diabetes. The ACN System fuses up to three joints in
order to relieve pain and restore activity.
The ACN Systems unique two-piece targeting assembly allows
for screw placement flexibility while ensuring improved stability and
simplicity throughout the procedure. In addition, the ACN allows for
independently controlled compression of the tibiotalar and subtalar joints. The
precision, robustness, and flexibility with respect to this critical aspect of
the procedure are unmatched within the industry.
Contours Lapidus Plating System (LPS)
While the ACN System represents the Companys entry into the hindfoot internal
fixation market, the Contours Lapidus Plating System (LPS) focuses on revision
procedures and joint fusion in the small bones of the midfoot. The Lapidus
surgical procedure is comprised of a tarsometatarsal (TMT) joint fusion to
treat patients with debilitating pain and discomfort that typically accompanies
hallux valgus (bunion deformities). The Contours LPS incorporates a plate
design contoured specifically for the TMT anatomy and the anatomical forces at
that joint, which leads to restoration of biomechanical properties and healing.
Orthofixs President and Chief Executive Officer Robert
Vaters stated, “The introduction of these two novel technologies highlights the
Companys commitment to the attractive U.S. foot and ankle market. While
Orthofix has a strong presence in external fixation, the bolstering of its
internal fixation offering along with its regenerative solutions creates an
attractive and differentiated value proposition for both orthopedic surgeons
and podiatrists.”
About Orthofix:
Orthofix International N.V. is a diversified, global medical device company
focused on developing and delivering innovative repair and regenerative
solutions to the spine and orthopedic markets. Orthofixs products are widely
distributed around the world to orthopedic surgeons and patients via Orthofixs
sales representatives and its subsidiaries, including BREG, Inc., and via
collaborations with other leading orthopedic product companies. In addition,
Orthofix is collaborating on R&D activities with leading research and
clinical organizations such as the Musculoskeletal Transplant Foundation, the
Orthopedic Research and Education Foundation, Texas Scottish Rite Hospital for
Children, and the Cleveland Clinical Foundation. For more information about
Orthofix, please visit www.orthofix.com.
